Hypertrophic Cardiomyopathy: New Frontiers (Cardiovascular Care Essentials 2026)
CME Credit Available:
This activity offers .75 1A AOA
Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Recognize and diagnose hypertrophic cardiomyopathy.
- Identify phenocopies of hypertrophic cardiomyopathy.
- Learn contemporary treatment strategies for hypertrophic cardiomyopathy.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Robby Wu, DO, faculty for this activity, has disclosed the following financial relationships: • Cytokinetics: Consulting/Speaker Bureau - Ongoing
• Bristol Myers Squibb: Consulting/Speaker Bureau - OngoingType – Role – Company
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Robby Wu, DO (he/him/his)
Advanced Heart Failure and Transplant Cardiologist
University of South Florida and Tampa General Hospital
Robby Wu, DO, is an assistant professor of medicine at the University of South Florida Morsani College of Medicine and an advanced heart failure and transplant cardiologist at Tampa General Hospital. He serves as medical director of Tampa General's Hypertrophic Cardiomyopathy Program and as associate program director of the USF Advanced Heart Failure and Transplant Cardiology fellowship.
Dr. Wu completed his undergraduate degrees in science and psychology at Pennsylvania State University and earned his medical degree at the Philadelphia College of Osteopathic Medicine in Philadelphia. He trained in internal medicine at Danbury Hospital, Yale School of Medicine, followed by a cardiovascular disease fellowship at Northside Hospital and the Tampa Bay Heart Institute and an advanced heart failure and transplant cardiology fellowship at Tampa General Hospital, USF Morsani College of Medicine. He is board certified in internal medicine, cardiovascular disease, and advanced heart failure and transplant cardiology, and is a diplomate of the National Board of Echocardiography.
His clinical and research interests span advanced heart failure, heart transplantation, mechanical circulatory support, and inherited cardiomyopathies. He serves as principal investigator on several multicenter trials, including SONATA-HCM, COMET-HF, and DRAIN-HF. His work has appeared in JACC: Heart Failure and the Journal of Heart and Lung Transplantation, and he has been invited to speak on hypertrophic cardiomyopathy, cardiogenic shock, and mechanical circulatory support at several national conferences.
Dr. Wu serves on the American College of Cardiology's Advanced Heart Failure and Transplant Cardiology Committee, chairs the USF Heart Failure Education Committee, and reviews for the Journal of Cardiac Failure. In 2025 he was named an American Heart Association Leader of Impact for Tampa Bay.
The faculty member, for this activity, has disclosed the following financial relationships:
- Cytokinetics: Consulting/Speaker Bureau – Ongoing
- Bristol Myers Squibb: Consulting/Speaker Bureau - Ongoing
Key:
Complete
Next
Failed
Available
Locked